2014
DOI: 10.3349/ymj.2014.55.3.676
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Genetic Aspects in Twelve Korean Patients with Adrenomyeloneuropathy

Abstract: PurposeThis study was designed to investigate the characteristics of Korean adrenomyeloneuropathy (AMN) patients.Materials and MethodsWe retrospectively selected 12 Korean AMN patients diagnosed by clinical analysis and increased plasma content of very long chain fatty acids.ResultsAll 12 patients were men. Patient ages at symptom onset ranged from 18 to 55 years. Family history was positive in two patients. The phenotype distributions consisted of AMN without cerebral involvement in seven patients, AMN with c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 23 publications
1
8
1
Order By: Relevance
“…A recent Korean genetic analysis of X-ALD showed a high rate of missense mutation (56%). [ 9 ] Our case concurs with these findings, as c.1876G>A is a known pathogenic missense mutation of the nucleotide binding domain. [ 10 ] The patient's mother was a carrier.…”
Section: Discussionsupporting
confidence: 87%
“…A recent Korean genetic analysis of X-ALD showed a high rate of missense mutation (56%). [ 9 ] Our case concurs with these findings, as c.1876G>A is a known pathogenic missense mutation of the nucleotide binding domain. [ 10 ] The patient's mother was a carrier.…”
Section: Discussionsupporting
confidence: 87%
“…The p.S108L mutation occurs at an evolutionarily highly conserved amino acid residue ( Fig 1C ), and the splice site mutation (c.1866-10G>A, p.P623fs) causes a frameshift of the coding sequence disrupting the ATP-binding cassette domain of ABCD1 . In the literature, nine mutations in ABCD1 had been identified in patients with AVALD ( Fig 1D ) [ 12 , 26 29 , 31 , 32 , 38 ]. Although the mutations p.P623fs and p.S108L had been previously reported in patients with ALD ( http://www.x-ald.nl/ ), they manifested as cerebral ALD or AMN rather than ataxia ( S2 Table ) [ 39 42 ].…”
Section: Resultsmentioning
confidence: 99%
“…Another limitation would be the lack of neuroradiological exam, which was only done in V-29. In the past, wide-ranged MRI pattern either on lesion location or isotopic diffusion/T2 pattern [ 5 , 39 - 41 ] were observed in X-ALD patients, and a strong association between the presence of contrast enhancement on T1-weighted MR images and X-linked ALD progression [ 42 ] has been identified.…”
Section: Discussionmentioning
confidence: 99%